InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001628280-26-014211 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2026-03-03 2026-02-27 OGN Morrissey Joseph T. Jr. Interim CEO A - Grant $0.00 +35.3K 98.8K +56% $0
M 2026-03-03 2026-02-27 OGN Morrissey Joseph T. Jr. Interim CEO F - Tax $7.18 -10.3K 98.6K -9% -$73.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-27 A A 27,564 $0.00 99,125.86 D — — (F1) Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2023 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
2 Common Common Stock 2026-02-27 F D 8,054 $7.17 91,071.86 D — —
3 Common Common Stock 2026-02-27 A A 7,777 $0.00 98,848.86 D — — (F2) Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
4 Common Common Stock 2026-02-27 F D 2,216 $7.23 98,570.92 D — — (F3) Includes the addition of 1,938.068 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.